Kostiantyn Rudenko

Prof. Kostiantyn Rudenko

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
PDF file
KRKostiantyn Rudenko
Kostiantyn Rudenko
VLVasyl V Lazoryshynets
Vasyl V Lazoryshynets
LNLidiia O Nevmerzhytska
Lidiia O Nevmerzhytska
MTMariia O Tregubova
Mariia O Tregubova
PDPolina A Danchenko
Polina A Danchenko
We studied 16 patients after failed alcohol septal ablation who underwent extended septal myectomy to analyse the results of surgical correction and identify technical pitfalls the surgeons may be confronted by. Between October 2017 and March 2019, 16 patients underwent surgical extended septal myectomy with accompanying anomalous secondary chordae resection, papillary muscles mobilization [in 9 (56.3%) patients], and anterior mitral leaflet plication after previously failed alcohol septal ablation. Routine preoperative computed tomography or cardiac magnetic resonance planning and intraoperative transoesophageal echocardiography were performed in each of the studied patients. Major technical features were identified and complemented during septal myectomy of the calcified interventricular septum. The mean age of the studied patients accounted 50.5 ± 14.6, median—54; males—5 (31.3%). Mean cross-clamp time accounted 52 ± 7.2 min. Calcified basal interventricular septum was identified in 2 (12.5%) patients. No iatrogenic ventricular septal defect (0%) was made during surgical correction. Peak systolic pressure gradient decreased from 86 (interquartile range: 75–104.7) to 20 (16–22) mmHg (P< 0.001). No patients with moderate or severe mitral regurgitation were identified, whereas before the procedure, the number of those accounted 13 (81.2%) individuals. In-hospital and overall mortality after septal myectomy accounted 0%. Extended septal myectomy in patients who previously underwent alcohol septal ablation is a safe procedure that affects all pathological manifestations of the disease. Routine preoperative computed tomography or cardiac magnetic resonance provides detailed anatomy of the anomalous left ventricle and subvalvular structures and allows to measure the extension of myectomy preventing the occurrence of iatrogenic ventricular septal defect. Septal myectomy of the calcified interventricular septum requires avoidance of ‘one-piece technique’ since fragmental myectomy allows visually control the adequacy of the left ventricle outflow tract release.

1 January 2020 in Problems of Radiation Medicine and Radiobiology
Verified
Journal Article
Open access
MTM. Tregubova
M. Tregubova
KRKostiantyn Rudenko
Kostiantyn Rudenko
VLV. Lazoryshynets
V. Lazoryshynets
SFS. Fedkiv
S. Fedkiv
OTO. Trembovetskaya
O. Trembovetskaya
YSYuriy Stukov
Yuriy Stukov
Background. Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy. Extended septal myectomy ( ESM) is one of the priority methods of treatment of drug-refractory obstructive HCM. In recent years, hospital mortality during surgical correction of obstructive HCM in expert centers does not exceed 1–2 %. However, typical threatening complications of septal myectomy, such as iatrogenic ventricular septal defect (VSD) and rupture of the anterior or posterior walls of the left ventricle (LV), remain a topical issue in surgery of HCM. Objective: to show the role of preoperative CT-planning to predict and reduce possible technical problems associated with ESM, including iatrogenic VSD. Methods and materials. This study includes 217 symptomatic patients with obstructive HCM, who from April 2016 to October 2019 as one of the steps of preoperative planning underwent cardiac CT prior to ESM. Cardiac CT was performed to delineate the left ventricular myocardium, assess the distribution of hypertrophy and the presence of crypts. Special attention was also paid to the anatomy of the mitral valve (MV) and subvalvular apparatus. Coronary artery patency was assessed by CAD-RADS, a standardized method for reporting the results of coronary CT angiography to determine tactics for further management of the patient. Results and discussion. In the study group, the average age of patients was (49 ± 15) years, 48 % – men. All patients had a symptomatic, drug-refractory obstructive form of HCM. The mean maximum wall thickness of the interventricular septum (IVS) was (20 ± 5) mm (range 16–33). The average LV mass was (118 ± 23) g/m2. 195 patients (89.9 %) had systolic anterior motion ( SAM) of the MV. MV and subvalvular apparatus anomalies were detected in 62 patients (28.6 %). A zone of scarring and regression of IVS after alcohol septal ablation (ASA) was detected in 7 patients (0.3 %) with residual LV outflow gradient. Coronary arteries atherosclerosis was detected in 32 patients (14.7 %). Conclusions. Preoperative CT-planning of septal myectomy allows to obtain information on morphology of the LV, IVS, MV and subvalvular apparatus, and gives the surgeon the advantage to form a more accurate plan for the location and volume of septal resection, and avoid complications when correcting obstructive HCM. No iatrogenic VSD was detected in any of the patient in the study group. Key words: hypertrophic cardiomyopathy, computed tomography, preoperative planning, extended septal myectomy.

31 May 2024 in Zaporozhye Medical Journal
Verified
Journal Article
Open access
PDF file
MIM. S. Ishchenko
M. S. Ishchenko
KRKostiantyn Rudenko
Kostiantyn Rudenko
VLV. V. Lazoryshynets
V. V. Lazoryshynets
YVYu. I. Vitkovskyi
Yu. I. Vitkovskyi
MTM. O. Tregubova
M. O. Tregubova
PDP. A. Danchenko
P. A. Danchenko
Hypertrophic cardiomyopathy (HCM) is a prevalent genetic heart disease with a worldwide prevalence. Its estimated incidence in young individuals is approximately 1 case per 500 population. HCM in adults can be clinically diagnosed through visualization, either via 2D echocardiography or cardiac magnetic resonance (CMR) imaging, where the maximum thickness of any left ventricular (LV) segment, measured in end-diastolic phase, is 15 mm in the absence of other hypertrophy causes. Aim. To demonstrate the role and diagnostic capabilities of CMR as a powerful diagnostic tool for detecting and evaluating sudden cardiac death (SCD) risk factors in patients with HCM. Materials and methods. From January 2022 to September 2023, 236 CMR examinations were conducted and analyzed at the Diagnostic Radiology Department of Amosov National Institute of Cardiovascular Surgery in patients with suspected HCM. All examinations were performed on a magnetic resonance tomograph “Toshiba Vantage Titan 1.5T” until May 2023, and “Canon Vantage Orian 1.5T” from May to September 2023, with ECG and respiratory synchronization as well as intravenous injection of gadolinium-based contrast agent (Gadovist 1.0) at a dose of 0.1 mL/kg body weight. Statistical and mathematical data processing was performed by using the Statistica 6.0 (StatSoft Inc., USA) application package. Results. The mean age of the examined patients was 41 ± 28 years, there were 142 male (60 %) and 94 (40 %) female patients. Symmetric non-obstructive HCM was identified in 39 patients (16.5 %) and 184 patients (78.0 %) had asymmetric obstructive HCM. Apical HCM was diagnosed in 4 patients (1.5 %), and midventricular HCM – in 9 patients (4.0 %) including one patient with a combination of midventricular and apical forms. Risk factors for SCD were identified in 60 patients (25.4 %) with myocardial thickness exceeding 30 mm, 8 patients (3.3 %) with apical aneurysm, 4 patients (1.6 %) with reduced LV systolic function (LV ejection fraction <50 %), and 164 patients (69.4 %) with pathological late gadolinium enhancement. Conclusions. CMR is a modern, high-precision and powerful diagnostic method that plays a key role in identifying and assessing SCD risk factors in patients with HCM. CMR helps to identify HCM patients at high SCD risk who may benefit from preventive measures such as implantable cardioverter-defibrillator therapy.

4 December 2024 in Zaporozhye Medical Journal
Verified
Journal Article
Open access
PDF file
OZO. O. Zhurba
O. O. Zhurba
VLV. V. Lazoryshynets
V. V. Lazoryshynets
ARA. V. Rudenko
A. V. Rudenko
KRKostiantyn Rudenko
Kostiantyn Rudenko
The aim to define the frequency of traditional smoking and electronic cigarette use among coronary heart disease (CHD) patients of different age groups. Materials and methods. The study included patients with CHD who underwent off-pump coronary artery bypass surgery (n = 3674). The mean age of the study participants was 60.6 ± 0.8 years. The material for analysis was anamnestic data regarding traditional smoking or the use of electronic nicotine delivery devices and a smoking history. The study design was based on the patient’s age group according to the WHO age classification. Results. The article raises an actual problem of defining the impact of electronic cigarettes and traditional smoking on health risk for CHD patients and the frequency of smoking types taking into account the patients’ age. Nicotine addiction has been revealed in 67.3 % of patients among the study participants that was significantly higher than the proportion of never-smokers, p = 0.0001, χ2 = 56.29. It has been found that 93.0 % of patients preferred traditional cigarette smoking to electronic cigarettes, p = 0.0001, χ2 = 2101.45, and the frequency of traditional smoking was significantly lower among young patients (21.3 %) as compared to older age groups of patients: middle-aged – 38.5 % (р = 0.0001, χ2 = 62.40), elderly – 44.0 % (р = 0.0001, χ2 = 116.53) and old-aged – 42.1 % (р = 0.0001, χ2 = 95.67). Smoking cessation frequency has been shown to be significantly higher in the older groups: middle-aged (p = 0.0001, χ2 = 17.42), elderly (p = 0.0001, χ2 = 15.59) and old-aged (p = 0.003, χ2 = 9.05) compared to that among CHD patients of a younger age. The determined frequency of using only electronic cigarettes as a smoking experience or transition from tradition smoking has been demonstrated to be significantly higher exclusively among young people compared to other age groups: middle-aged patients (p = 0.0001, χ2 = 170.24), elderly (p = 0.0001, χ2 = 288.63) and old-aged (p = 0.0001, χ2 = 290.01). Conclusions. Tobacco smoking as one of the leading risk factors has been established to be an extremely common phenomenon in the sample of CHD patients with the frequency of 67.3 %, that was significantly higher than the number of never-smokers, p = 0.0001, χ2 = 56.29. The rates demonstrating the prevalence of traditional and electronic cigarette smoking based on the age of patients with coronary heart disease have been determined. The incidence of smoking status types (quit smoking, switch to electronic cigarettes, dual users) according to the age aspect has been revealed.

15 December 2025 in Indian Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
PDPolina Danchenko
Polina Danchenko
KRKostiantyn Rudenko
Kostiantyn Rudenko
MRMaksym Rzhanyi
Maksym Rzhanyi
LHLiliana Hrubiak
Liliana Hrubiak
MIMykhailo Ishchenko
Mykhailo Ishchenko
MKMykhailo Kozhanov
Mykhailo Kozhanov

1 March 2022 in Zaporozhye Medical Journal
Verified
Journal Article
Open access
PDF file
NVN. I. Voloshchuk
N. I. Voloshchuk
KRKostiantyn Rudenko
Kostiantyn Rudenko
OMO. R. Matiash
O. R. Matiash
ODO. M. Denysiuk
O. M. Denysiuk
Aim: systematization of knowledge about the pathobiochemical mechanisms of heart disease in alcoholic cardiomyopathy (ACMP) and the search for promising ways of cardiocytoprotection. Alcohol abuse is an important medical and social problem, risk factor for metabolic disorders, malnutrition, cancers, dementia, neuropathy, and others. Consumption of large amounts of ethanol increases a risk of sudden cardiac death and cardiac arrhythmias. The term "alcoholic cardiomyopathy" describes a heart disease in people with a history of long-term alcohol use. ACMP is characterized by left ventricular dilatation, decreased wall thickness and (at the later stages) decreased left ventricular ejection fraction (less than 40 %). Analysis of literature data about the mechanisms of alcohol-induced cardiotoxicity revealed trigger factors for myocardial damage. Negative effect of ethanol on the heart is realized through induction of oxidative-nitrosative stress, apoptosis, inflammation, fibrogenesis, hypoenergetic state and ion pump dysfunction, development of endothelial dysfunction, impaired ribosomal synthesis. In-depth study of biochemical mechanisms and identification of new molecular targets, integrated into the pathogenesis of ACMP, will optimize the pharmacotherapy for this pathology. Hydrogen sulfide (H2S), is a metabolic factor involved in the regulation of cardiovascular activity. Use of exogenous H2S has potent cardioprotective properties in cardio-vascular diseases. Donors of H2S and H2S-releasing drugs (hybrid molecules - H2S-aspirin, H2S-NO) show a powerful cardioprotective role in various pathological conditions. Therefore, it is advisable to further study the role of H2S system in the pathogenesis of ACMP to develop new approaches to more effective treatment of this disease. Conclusions. Modulation of the H2S level in the organism may be a predictor of the severity of myocardial damage, as well as a promising vector in pharmacotherapy, including alcoholic cardiomyopathy.